Zai Lab Limited (HKG:9688)
Hong Kong
· Delayed Price · Currency is HKD | Market Cap | 16.64B |
| Revenue (ttm) | 3.58B |
| Net Income (ttm) | -1.37B |
| Shares Out | n/a |
| EPS (ttm) | -12.47 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 11,187,380 |
| Average Volume | 9,304,268 |
| Open | 15.19 |
| Previous Close | 14.48 |
| Day's Range | 14.74 - 15.70 |
| 52-Week Range | 12.31 - 35.50 |
| Beta | 0.89 |
| RSI | 55.23 |
| Earnings Date | Feb 26, 2026 |
About Zai Lab
Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy; NUZYRA for community-acquired bacterial pneumonia and acute bacter... [Read more]
Financial Performance
In 2025, Zai Lab's revenue was $460.16 million, an increase of 15.33% compared to the previous year's $398.99 million. Losses were -$175.54 million, -31.73% less than in 2024.
Financial numbers in USD Financial StatementsNews
Zai Lab Limited 2025 Q4 - Results - Earnings Call Presentation
Decoding Zai Lab Ltd (ZLAB): A Strategic SWOT Insight
Decoding Zai Lab Ltd (ZLAB): A Strategic SWOT Insight
Zai Lab Ltd (ZLAB) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Zai Lab Ltd (ZLAB) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements
Q4 2025 Zai Lab Ltd Earnings Call Transcript
Q4 2025 Zai Lab Ltd Earnings Call Transcript
Zai Lab Limited (ZLAB) Q4 2025 Earnings Call Transcript
Zai Lab Limited (ZLAB) Q4 2025 Earnings Call Transcript
Zai Lab Limited (ZLAB) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Zai Lab Limited (ZLAB) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with W...
Zai Lab: Q4 Earnings Insights
Zai Lab (NASDAQ: ZLAB) released its Q4 earnings on Thursday, February 26, 2026 at 07:00 AM. Here's what's important from the earnings announcement. Earnings Zai Lab missed estimated earnings by -6.98...
Zai Lab (ZLAB) Exceeds Revenue Expectations in Q4
Zai Lab (ZLAB) Exceeds Revenue Expectations in Q4
Zai Lab Q4 Earnings Summary & Key Takeaways
The Q4 earnings report for Zai Lab (NASDAQ: ZLAB) was released on Thursday, February 26, 2026 at 07:00 AM. Here's what investors need to know about the latest announcement. Earnings Zai Lab beat esti...
Zai Lab Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for the fourth quarter and full-year 2025, along with recent product highligh...
An Overview of Zai Lab's Earnings
Zai Lab (NASDAQ: ZLAB) is preparing to release its quarterly earnings on Thursday, 2026-02-26. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect Z...
Baron Emerging Markets Fund Q4 2025 Portfolio Activity
During Q4, Baron Emerging Markets Fund added a few new investments to existing themes while also increasing exposure to several positions that we established in earlier periods. SK hynix has emerged a...
RTW INVESTMENTS, LP's Strategic Acquisition of Zai Lab Ltd Shares
RTW INVESTMENTS, LP's Strategic Acquisition of Zai Lab Ltd Shares
Zai Lab Limited (ZLAB) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript
Zai Lab Limited (ZLAB) Citi's 2026 Virtual Oncology Leadership Summit February 19, 2026 2:30 PM ESTCompany ParticipantsRafael Amado - President and Head of...
Zai Lab to Announce Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates on February 26, 2026
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report its fourth quarter and full year 2025 financial results and provide recent ...
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go ...
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Zai Lab Limited (ZLAB) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
Zai Lab Ltd at JPMorgan Healthcare Conference Transcript
Zai Lab Ltd at JPMorgan Healthcare Conference Transcript
Zai Lab Limited (ZLAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Zai Lab Highlights Strategic Priorities and Global Pipeline Progress at 44th Annual J.P. Morgan Healthcare Conference
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today provided an update on the Company's 2026 strategic priorities and clinical development progress. These up...
Zai Lab Announces National Medical Products Administration (NMPA) Approval of AUGTYRO™ (repotrectinib) for Patients with NTRK-Positive Solid Tumors
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China's National Medical Products Administration (NMPA) has approved the supplemental New ...
Zai Lab to Present at 44th Annual J.P. Morgan Healthcare Conference
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company's senior management team will participate in the 44th Annual J.P. M...
After-Hours Gainers: GH Research, Phathom, Forte, OKYO, Zai Lab, LifeMD, Werewolf & Corvus Rally
(RTTNews) - Biotech names dominated the after-hours session on Friday, with several companies posting notable gains despite limited news catalysts.